Outcomes of pelvic and para-aortic stereotactic reirradiation for gynaecological cancer recurrence
In selected patients with oligometastatic pelvic or para-aortic relapse of gynaecological cancer following previous pelvic radiotherapy, SBRT reirradiation is an effective and safe treatment modality. SBRT reirradiation can provide durable local control and delay time to further treatment by more than 12 months.
Authors
- Ian Zing Tan
- Susan Lalondrelle (ORCID: https://orcid.org/0000-0002-1147-3618)
- Kallol Bhadra
- Lei Wang (ORCID: https://orcid.org/0000-0002-2609-9139)
- Benjamin J. Thomas (ORCID: https://orcid.org/0000-0002-8836-0902)
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- Institute of Cancer Research (GB)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1016/j.ctro.2025.101060
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Royal Marsden NHS Foundation Trust
- National Institute for Health and Care Research
- Department of Health and Social Care